Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad A Dickey

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Expert Opinion on Therapeutic Targets|September 20, 2006
Current strategies for the treatment of Alzheimer's disease and other tauopathiesChad A Dickey, Leonard Petrucelli
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discovery." The last stand: the dichotomy of chaperone function in Alzheimer's diseaseChad A Dickey, Leonard Petrucelli
Methods in Molecular Biology (Clifton, N.J.)|October 23, 2010
Cell-based assays for regulators of tau biologyUmesh K Jinwal, Chad A Dickey
Frontiers in Neuroscience|February 3, 2016
The Metamorphic Nature of the Tau Protein: Dynamic Flexibility Comes at a CostJonathan J Sabbagh, Chad A Dickey
The American Journal of Pathology|October 4, 2011
The earliest tau dysfunction in Alzheimer's disease? Tau phosphorylated at s422 as a toxic seedKellen Voss, John Koren, Chad A Dickey
Current Enzyme Inhibition|June 27, 2013
Reconstructing the Hsp90/Tau MachineUmesh K Jinwal, John Koren, Chad A Dickey
Experimental Neurology|January 10, 2013
A commentary on: Modulating molecular chaperones improves sensory fiber recovery and mitochondrial function in diabetic peripheral neuropathyKaitlyn Braswell, Chad A Dickey, Umesh K Jinwal
Nature Structural & Molecular Biology|January 5, 2013
A global view of Hsp90 functionsGabriela Chiosis, Chad A Dickey, Jill L Johnson
Journal of Molecular Neuroscience : MN|May 12, 2011
Neuronal life span versus health span: principles of natural selection at work in the degenerating brainJohn C O'Leary, John Koren, Chad A Dickey
Alzheimer'S Research & Therapy|September 18, 2013
Potential synergy between tau aggregation inhibitors and tau chaperone modulatorsLaura J Blair, Bo Zhang, Chad A Dickey
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Expert Opinion on Therapeutic Targets|September 20, 2006
Current strategies for the treatment of Alzheimer's disease and other tauopathiesChad A Dickey, Leonard Petrucelli
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discovery." The last stand: the dichotomy of chaperone function in Alzheimer's diseaseChad A Dickey, Leonard Petrucelli
Methods in Molecular Biology (Clifton, N.J.)|October 23, 2010
Cell-based assays for regulators of tau biologyUmesh K Jinwal, Chad A Dickey
Frontiers in Neuroscience|February 3, 2016
The Metamorphic Nature of the Tau Protein: Dynamic Flexibility Comes at a CostJonathan J Sabbagh, Chad A Dickey
The American Journal of Pathology|October 4, 2011
The earliest tau dysfunction in Alzheimer's disease? Tau phosphorylated at s422 as a toxic seedKellen Voss, John Koren, Chad A Dickey
Current Enzyme Inhibition|June 27, 2013
Reconstructing the Hsp90/Tau MachineUmesh K Jinwal, John Koren, Chad A Dickey
Experimental Neurology|January 10, 2013
A commentary on: Modulating molecular chaperones improves sensory fiber recovery and mitochondrial function in diabetic peripheral neuropathyKaitlyn Braswell, Chad A Dickey, Umesh K Jinwal
Nature Structural & Molecular Biology|January 5, 2013
A global view of Hsp90 functionsGabriela Chiosis, Chad A Dickey, Jill L Johnson
Journal of Molecular Neuroscience : MN|May 12, 2011
Neuronal life span versus health span: principles of natural selection at work in the degenerating brainJohn C O'Leary, John Koren, Chad A Dickey
Alzheimer'S Research & Therapy|September 18, 2013
Potential synergy between tau aggregation inhibitors and tau chaperone modulatorsLaura J Blair, Bo Zhang, Chad A Dickey
Pageof 11